Dr. Agarwal’s Revenue Jumps 20.2% to ₹1,007 Cr in H1’FY26

Dr. Agarwal’s Health Care reported robust growth in H1’FY26, with revenue reaching ₹1,007 Cr, a 20.2% increase YoY. EBITDA rose by 24.9% to ₹285 Cr, while profit after tax surged 88.4% to ₹75 Cr. The company expanded its network to 258 eye care facilities, serving over 1.4 million patients and performing over 157,000 surgeries.

Key Financial Highlights

Dr. Agarwal’s Health Care showcased strong financial performance in H1’FY26:

  • Total Income: ₹1,007 Cr, up 20.2% YoY
  • EBITDA: ₹285 Cr, a 24.9% increase YoY
  • Profit After Tax: ₹75 Cr, soaring 88.4% YoY

Operational Performance

The company significantly expanded its operational footprint:

  • Number of Eye Care Facilities: 258
  • Patients Served: 1,435,024
  • Surgeries Performed: 157,281
  • Number of Doctors: 881

Geographic Footprint

Dr. Agarwal’s has a wide-reaching presence:

  • India: Operations across 14 states and 5 Union Territories
  • Africa: Operations in 9 countries

Revenue Mix

The revenue composition shows a balanced approach:

  • Surgeries: 12.8% of H1’FY25 revenue, 13.2% in H1’FY26
  • Diagnosis, Consultations, & Others: 8.0% of H1’FY25 revenue, 8.4% in H1’FY26
  • Opticals, Contact Lens and Accessories: 13.6% of H1’FY25 revenue, 11.9% in H1’FY26
  • Eye Care Related Pharma Products: 65.6% of H1’FY25 revenue, 66.5% in H1’FY26

Expansion Plans

The company is set to continue expanding its network:

  • Planned addition of 54 facilities in the upcoming three quarters.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!